Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana 1000, Slovenia.
Clinical Hospital Center Sestre Milosrdnice and University of Zagreb Medical School, Zagreb 10 000, Croatia.
Exp Biol Med (Maywood). 2020 Mar;245(5):456-464. doi: 10.1177/1535370220905560. Epub 2020 Feb 10.
NANOG is an important stem cell transcription factor involved in human development and cancerogenesis. Its expression is complex and regulated on different levels. Moreover, NANOG protein might regulate hundreds of target genes at the same time. NANOG is crucial for preimplantation development phase and progressively decreases during embryonic stem cells differentiation, thus regulating embryonic and fetal development. Postnatally, NANOG is undetectable or expressed in very low amounts in the majority of human tissues. NANOG re-expression can be detected during cancerogenesis, already in precancerous lesions, with increasing levels of NANOG in high grade dysplasia. NANOG is believed to enable cancer cells to obtain stem-cell like properties, which are believed to be the source of expanding growth, tumor maintenance, metastasis formation, and tumor relapse. High NANOG expression in cancer is frequently associated with advanced stage, poor differentiation, worse overall survival, and resistance to treatment, and is therefore a promising prognostic and predictive marker. We summarize the current knowledge on the role of NANOG in cancerogenesis and development, including our own experience. We provide a critical overview of NANOG as a prognostic and diagnostic factor, including problems regarding its regulation and detection.
NANOG has emerged as a key stem cell transcription factor in normal development and cancerogenesis. It is generally regarded as a good prognostic and predictive factor in various human cancers. It is less known that it is expressed already at precancerous stages in various organs, suggesting that finally an ideal candidate diagnostic marker has been discovered, enabling to distinguish between true dysplasia and reactive atypia. NANOG regulation is complex, and new insights into our understanding of its regulation might provide important information for future development in a broad field of two entirely different processes, i.e. normal development and cancerogenesis, showing how a physiologic mechanism can be used and abused, transforming itself into a key mechanism of disease development and progression.
NANOG 是一种重要的干细胞转录因子,参与人类发育和癌症发生。其表达复杂,受不同水平的调节。此外,NANOG 蛋白可能同时调节数百个靶基因。NANOG 对植入前发育阶段至关重要,并在胚胎干细胞分化过程中逐渐减少,从而调节胚胎和胎儿发育。出生后,NANOG 在大多数人体组织中无法检测到或表达量极低。在癌症发生过程中可以检测到 NANOG 的重新表达,甚至在癌前病变中就可以检测到,高级别发育不良中的 NANOG 水平逐渐升高。人们认为 NANOG 使癌细胞获得类似干细胞的特性,这些特性被认为是扩大生长、肿瘤维持、转移形成和肿瘤复发的来源。癌症中 NANOG 的高表达通常与晚期、低分化、总体生存较差和治疗耐药性相关,因此是一种有前途的预后和预测标志物。我们总结了 NANOG 在癌症发生和发展中的作用的现有知识,包括我们自己的经验。我们批判性地概述了 NANOG 作为预后和诊断因素的作用,包括其调节和检测方面的问题。
NANOG 已成为正常发育和癌症发生中的关键干细胞转录因子。它通常被认为是各种人类癌症的良好预后和预测因素。鲜为人知的是,它已经在各种器官的癌前阶段表达,这表明最终发现了一种理想的候选诊断标志物,能够区分真正的发育不良和反应性异型性。NANOG 的调节很复杂,对其调节的新认识可能为正常发育和癌症发生这两个完全不同的过程的广泛领域的未来发展提供重要信息,展示了生理机制如何被利用和滥用,将自身转变为疾病发展和进展的关键机制。